A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

NCT04372186 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Placebo
DRUG: Tocilizumab

Sponsor

Genentech, Inc.